Literature DB >> 27061173

Influence of Phosphatidylethanolamine Concentration and Composition on the Detection of Antiphosphatidylethanolamine Antibodies by ELISA.

Ke Ke1, Zachariah I Strango2, Paul E Harper2, Ming Zhao3.   

Abstract

BACKGROUND: Accumulating evidence supports a positive correlation between the presence of antiphosphatidylethanolamine (aPE) autoantibodies and clinical symptoms of antiphospholipid syndrome (APS). However, there is a lack of standardized ELISA-based method for detecting aPE. The current study was conducted to investigate the dependence of aPE ELISA on lipid concentration and composition of PE antigens.
METHODS: A range of ELISA conditions were examined by varying the concentrations of egg PE and by substituting egg PE with combinations of synthetic DOPE and DSPE. The physical properties of the synthetic PE species were also characterized.
RESULTS: Our data indicated that there are different optimal PE concentrations for conducting ELISA assays for cofactor-dependent and cofactor-independent aPEs. In addition, using a two-component synthetic lipid system, we demonstrated aPE ELISA readouts can be modulated to approach the performance level of egg PE, which is currently the most commonly used PE antigen.
CONCLUSION: These data raised the possibility of ultimately replacing natural PE antigens with a blend of defined synthetic lipid species, thus overcoming a known variable factor in aPE detection. The outcome of this study will help pave the way to developing a standardized aPE test.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  antiphosphatidylethanolamine antibodies; antiphospholipid syndrome; phosphatidylethanolamine

Mesh:

Substances:

Year:  2016        PMID: 27061173      PMCID: PMC5042802          DOI: 10.1002/jcla.21923

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  20 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  The fatty acids of phosphatidylethanolamine and phosphatidylcholine from hen's egg.

Authors:  J C HAWKE
Journal:  Biochem J       Date:  1959-03       Impact factor: 3.857

3.  Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS').

Authors:  Jose Luis Rodriguez-Garcia; Maria Laura Bertolaccini; Maria Jose Cuadrado; Giovanni Sanna; Oier Ateka-Barrutia; Munther A Khamashta
Journal:  Ann Rheum Dis       Date:  2011-09-27       Impact factor: 19.103

4.  Syndrome of the black swan.

Authors:  E N Harris
Journal:  Br J Rheumatol       Date:  1987-10

5.  Microtitre plate and assay buffer alter detection of antiphosphatidylethanolamine antibodies in lupus anticoagulant positive plasma.

Authors:  K A Drouvalakis; R R Buchanan
Journal:  Thromb Res       Date:  1999-05-15       Impact factor: 3.944

6.  Determination of L(alpha)-H(II) phase transition temperature for 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine.

Authors:  Gilman E S Toombes; Adam C Finnefrock; Mark W Tate; Sol M Gruner
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

7.  Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity.

Authors:  M C Boffa; M Berard; T Sugi; J A McIntyre
Journal:  J Rheumatol       Date:  1996-08       Impact factor: 4.666

8.  Antiphosphatidylethanolamine antibody as the sole antiphospholipid antibody in systemic lupus erythematosus with thrombosis.

Authors:  M Karmochkine; P Cacoub; J C Piette; P Godeau; M C Boffa
Journal:  Clin Exp Rheumatol       Date:  1992 Nov-Dec       Impact factor: 4.473

Review 9.  Anti-phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome.

Authors:  Henrique Luiz Staub; Maria Laura Bertolaccini; Munther A Khamashta
Journal:  Autoimmun Rev       Date:  2012-07-13       Impact factor: 9.754

10.  Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.

Authors:  Marielle Sanmarco; Stéphane Gayet; Marie-Christine Alessi; Marie Audrain; Emmanuel de Maistre; Jean-Christophe Gris; Philip G de Groot; Eric Hachulla; Jean-Robert Harlé; Pierre Sié; Marie-Claire Boffa
Journal:  Thromb Haemost       Date:  2007-06       Impact factor: 5.249

View more
  3 in total

1.  Impaired ankle-brachial index in antiphospholipid syndrome: Beyond the traditional risk factors.

Authors:  Simona Caraiola; Ciprian Jurcut; Alina Dima; Ruxandra Jurcut; Cristian Baicus; Anda Baicus
Journal:  J Clin Lab Anal       Date:  2018-07-10       Impact factor: 2.352

2.  Comparison of different enzyme-linked immunosorbent assay methods for avidity determination of antiphospholipid antibodies.

Authors:  Lenka Fialová; Milada Petráčková; Oliver Kuchař
Journal:  J Clin Lab Anal       Date:  2017-01-26       Impact factor: 2.352

3.  The outcome of ELISA for antiphosphatidylethanolamine antibodies is dependent on the composition of phosphatidylethanolamine.

Authors:  Songwang Hou; Paul E Harper; Nathalie Bardin; Ming Zhao
Journal:  J Immunol Methods       Date:  2016-10-23       Impact factor: 2.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.